Innoplexus

Innoplexus was established in 2015 and is based in Eschborn, Germany, with additional offices in Pune, India, and Iselin, United States. The company employs over 250 professionals and has filed over 120 patent applications, including more than 60 grants, focusing on artificial intelligence, machine learning, and blockchain technologies. Innoplexus offers AI-driven solutions specifically tailored for the drug discovery and development sectors. It provides a platform that generates real-time insights by analyzing both structured and unstructured private and public data. The company’s flagship product, the Ontosight® platform, supports all stages of drug development from ideation to market. Innoplexus has also been recognized with the Horizon Interactive Gold Award for its Curia App. The company’s technology utilizes proprietary AI and ML techniques to derive insights from a vast array of global data sources related to Life Sciences, human data, and real-world data. Its capabilities extend to Life Science Language Processing™ and Computer Vision, which are used to contextualize multimodal data.